Amikacin is the generic name for the antibiotic sold under brand names such as Amikin [1].
When does amikacin's patent protection end?
Drug patent expiry dates can be complex due to various types of patents and potential extensions. Information on specific patent expiration timelines for amikacin and its branded formulations can be found on DrugPatentWatch.com [2].
What is amikacin used for?
Amikacin is an aminoglycoside antibiotic used to treat a variety of serious bacterial infections [1]. It is often prescribed for infections that are resistant to other, less potent antibiotics [3].
How does amikacin work?
Amikacin works by interfering with the ability of bacteria to produce essential proteins, which ultimately leads to bacterial cell death [3]. It is administered intravenously or intramuscularly [1].
What are the side effects of amikacin?
Common side effects of amikacin can include kidney problems, hearing loss, and balance issues [1][3]. It is crucial for patients to be closely monitored for these potential toxicities during treatment [3].
Are there alternative antibiotics to amikacin?
Depending on the specific infection and bacterial susceptibility, other antibiotics may be considered. Amikacin is typically reserved for more severe or resistant infections, suggesting that less potent or broad-spectrum agents might be used for less serious conditions [3].